The effect of icotinib or apatinib on the pharmacokinetic profile of oxycodone in rats and the underlying mechanism
Qi Zhou, Feng Ye, Zhize Ye, Nanyong Gao, Qihui Kong, Xiaoqin Hu, Jianchang Qian, Bin Wu · 2023
Read The effect of icotinib or apatinib on the pharmacokinetic profile of oxycodone in rats and the underlying mechanism by Qi Zhou, Feng Ye, Zhize Ye, Nanyong Gao, Qihui Kong, Xiaoqin Hu, Jianchang Qian, Bin Wu (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10712305.txt.
Description
Zhou and seven co-authors checked painkiller interactions in rats in this study from twenty twenty-three. Oxycodone is cleared by liver enzymes that cancer drugs can block. The team dosed rats with oxycodone alone and beside two targeted cancer drugs, icotinib and apatinib. A sensitive assay tracked the painkiller and its breakdown product.
Icotinib raised total oxycodone exposure while slowing its clearance. Apatinib mainly lifted the peak concentration. In liver preparations from rats and humans, both drugs inhibited oxycodone breakdown. The inhibition patterns differed by species and drug. The authors advise reconsidering oxycodone doses when the drugs are combined. The work is preclinical, in animals and lab tissue.
Catalog record
| CREATOR | Qi Zhou, Feng Ye, Zhize Ye, Nanyong Gao, Qihui Kong, Xiaoqin Hu, Jianchang Qian, Bin Wu |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |